Anya Hammann‐Haenni

Nano‐particle vaccination combined with <scp>TLR</scp>‐7 and ‐9 ligands triggers memory and effector <scp>CD</scp>8⁺<scp>T</scp>‐cell responses in melanoma patients

Simone M. Goldinger, Reinhard Dummer, Petra Baumgaertner et al. · European Journal of Immunology · 2012 · 191 citations · Full text

The novel TLR-9 agonist QbG10 shows clinical efficacy in persistent allergic asthma

Kai-Michael Beeh, Frank Kanniess, Frank Wagner et al. · Journal of Allergy and Clinical Immunology · 2013 · 163 citations

Asthma, Allergy, Allergy Medicine +8

Assessment of clinical efficacy of CYT003‐QbG10 in patients with allergic rhinoconjunctivitis: a phase IIb study

Ludger Klimek, Jörg Willers, Anya Hammann‐Haenni et al. · Clinical & Experimental Allergy · 2011 · 141 citations

Virus‐like particles induce robust human T‐helper cell responses

Marion Braun, Camilla Jandus, Patrik Maurer et al. · European Journal of Immunology · 2011 · 77 citations · Full text

Adaptive Immune System, Humoral Response, Immunology +21

<scp>CYT</scp>003, a <scp>TLR</scp>9 agonist, in persistent allergic asthma – a randomized placebo‐controlled Phase 2b study

Thomas B. Casale, Jeremy Cole, Ekkehard Beck et al. · Allergy · 2015 · 67 citations